AR056674A1 - Anticoncepcion oral con trimegestona - Google Patents

Anticoncepcion oral con trimegestona

Info

Publication number
AR056674A1
AR056674A1 ARP060103101A ARP060103101A AR056674A1 AR 056674 A1 AR056674 A1 AR 056674A1 AR P060103101 A ARP060103101 A AR P060103101A AR P060103101 A ARP060103101 A AR P060103101A AR 056674 A1 AR056674 A1 AR 056674A1
Authority
AR
Argentina
Prior art keywords
trimegestone
oral contraception
contraception
successive days
woman
Prior art date
Application number
ARP060103101A
Other languages
English (en)
Inventor
Oliver Gloger
Heinrich Kugelmann
Mario Popova
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102005034498A external-priority patent/DE102005034498A1/de
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of AR056674A1 publication Critical patent/AR056674A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Método para la anticoncepcion que comprende la administracion de trimegestona junto con etinilestradiol a una mujer en edad fértil en al menos 21 días sucesivos, comenzando el día 1 del ciclo menstrual, en el que en al menos uno de los al menos 21 días sucesivos la dosis diaria de trimegestona es superior a 500 ?g.
ARP060103101A 2005-07-20 2006-07-19 Anticoncepcion oral con trimegestona AR056674A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005034498A DE102005034498A1 (de) 2005-07-20 2005-07-20 Orale Kontrazeption mit Trimegeston
US11/348,545 US20070021396A1 (en) 2005-07-20 2006-02-06 Oral contraception with trimegestone

Publications (1)

Publication Number Publication Date
AR056674A1 true AR056674A1 (es) 2007-10-17

Family

ID=37075980

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103101A AR056674A1 (es) 2005-07-20 2006-07-19 Anticoncepcion oral con trimegestona

Country Status (6)

Country Link
EP (1) EP1909799A1 (es)
KR (1) KR20080031435A (es)
AR (1) AR056674A1 (es)
AU (1) AU2006271920A1 (es)
CA (1) CA2615427A1 (es)
WO (1) WO2007009769A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004246A2 (en) * 1996-07-26 1998-02-05 American Home Prod Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
FR2801218B1 (fr) * 1999-11-23 2001-12-28 Hoechst Marion Roussel Inc Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant

Also Published As

Publication number Publication date
AU2006271920A1 (en) 2007-01-25
CA2615427A1 (en) 2007-01-25
KR20080031435A (ko) 2008-04-08
WO2007009769A1 (en) 2007-01-25
EP1909799A1 (en) 2008-04-16

Similar Documents

Publication Publication Date Title
ECSP088123A (es) Anticoncepcion oral con trimegestona
CR7611A (es) Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona
AR054525A1 (es) Composiciones y metodos para eltratamiento de sintomas relacionados con el ciclo
AR057060A1 (es) Composiciones de tanaproget que contienen etinil estradiol
ES2693085T1 (es) Uso de estriol en bajas dosis
AR077199A1 (es) Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia
AR032204A1 (es) Complejos de inclusion de ciclodextrina-drospirenona
RS53876B1 (en) PARENTERAL PHARMACEUTICAL FORM, WHICH RELEASES AROMATASE AND GESTAGEN BLOCKERS, FOR THE TREATMENT OF ENDOMETRIOSIS
BR0313921A (pt) Regime de reposição de estrogênio
HN2008000621A (es) Metodo para la anticopcepcion hormonal preventiva bajo demanda
UY30461A1 (es) Composicion farmacéutica para la anticoncepcion y para reducir el riesgo de malformaciones congénitas.
PE20061314A1 (es) Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo
PE20211588A1 (es) Compuestos y sus usos para aliviar sintomas asociados a la menopausia
PE20081895A1 (es) Regimen anticonceptivo oral
ES2563068T3 (es) Tratamiento de esclerosis múltiple (MS) con Campath-1H
CO2019000604A2 (es) Composición vaginal que comprende una combinación de estrógeno y vitamina d
GT200900296A (es) Composición farmacéutica que comprende la combinación de un agente anti inflamatorio no esteroideo y un agente anticonvulsivante.
SV2009003168A (es) Derivados de oxazolidona como moduladores pr
ES2574999T3 (es) Método para la contracepción a demanda usando levonorgestrel o norgestrel
UY29861A1 (es) Uso de valerato de estradiol en combinación con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral
AR056674A1 (es) Anticoncepcion oral con trimegestona
AR048068A1 (es) Piperazinas derivadas de urea para el tratamiento de endometriosis
AR044831A1 (es) Forma de administracion inyectable de la flupirtina
AR057155A1 (es) Metodo de administracion de la 5-(2-clorofenil)-1,2-dihidro-7-fluor-8-metoxi-3-metil-pirazolo[3,4-b][1,4]benzodiazepina
ECSP099482A (es) Preparación farmacéutica para reducir la endometriosis

Legal Events

Date Code Title Description
FB Suspension of granting procedure